Melanoma may not become steadily more dangerous with age as scientists once assumed. A new study published in ScienceDaily reveals that cancer spread was lowest in young mice, surged in middle-aged mice, and then dropped again in very old mice. The finding challenges long-held assumptions about cancer progression across the lifespan.
The research identifies a special type of immune cell that helps keep cancer dormant and prevents it from spreading. This cell appears to be most active in very old mice, offering a potential explanation for the age-related decline in metastasis. Why this immune mechanism weakens in middle age remains unclear.
In the study, metastasis rates followed a distinct U-shaped curve: low in youth, high in middle age, and low again in old age. The pattern was unexpected, as previous models often assumed a linear increase in cancer risk with age. The results were consistent across multiple experimental conditions.
If confirmed in humans, the discovery could change how oncologists assess metastasis risk for older patients. It also suggests that treatments boosting the activity of these immune cells might help prevent cancer spread, particularly in middle-aged individuals who appear most vulnerable.
A key caveat: the study was conducted in mice, and human biology may differ. Further research is needed to confirm whether the same immune mechanism operates in people.